Faculty
Genevieve Kanter
Associate Professor
Programs
Education
PhD in Economics and Sociology, University of Chicago
Expertise
Health economics
Health policy
FDA
Pharmaceuticals and medical devices
Conflicts of interest
Physician-industry relationships
Medical ethics
Biography
Genevieve P. Kanter, PhD, is Associate Professor of Public Policy at the USC Price School of Public Policy.
She is an economist whose research focuses on the FDA and regulatory issues related to biomedical technologies; financial conflicts of interest; industry relationships and industry influence in medicine; and hospital and physician payment models.
Professor Kanter’s research and essays have been published in leading academic journals, including the New England Journal of Medicine, JAMA, and Health Affairs, and her work and expert commentary have been featured in major media outlets, including the New York Times, Wall Street Journal, Washington Post, Reuters, AP, NPR, CNBC, and Politico.
She serves on the Medicare Evidence Development & Coverage Advisory Committee (the federal advisory committee for Medicare coverage) and is on the Editorial Board of the journal BMC Medical Ethics.
Professor Kanter received a PhD in Economics and in Sociology from the University of Chicago; completed an NIH postdoctoral fellowship in health and demography at Princeton University; and completed research fellowships in health policy and ethics at Massachusetts General Hospital and Harvard University.
Selected Publications
- Guadamuz, J. S., Alexander, G. C., Kanter, G. P., & Qato, D. M. (2025). Medicare part D preferred pharmacy networks and the risk for pharmacy closure, 2014–23. Health Affairs, 44(5), 539–545.
- Mccoy, M. S., Gaines, M. E., Joffe, S., Kanter, G. P., Largent, E. A., Lo, B., Lynch, H. F., Whelan, A. M., & Mello, M. M. (2025). A framework for assessing the permissibility of academic leaders’ outside activities. The Milbank Quarterly.
- Greenberg, K. S., Hopen, J., Draw, M., McCoy, M. S., Kanter, G. P., & Lynch, H. F. (2025). Difficulty with binary voting among FDA Oncology Advisory Committee members. JAMA Network Open, 8(7).
- Wu, J., Kanter, G. P., Wagner, T. H., Chu, D., Cashy, J. P., Prigge, J. M., Glorioso, T. J., Rahman, N., Murali, N., Giri, J., Nathan, A. S., Waldo, S. W., & Groeneveld, P. W. (2025). Impact of the mission act on quality and outcomes of major cardiovascular procedures among veterans. JAMA, 334(8), 702.
- Holmgren, A. J., Apathy, N. C., & Kanter, G. P. (2025). Electronic health record market consolidation and implications for Cybersecurity. Health Affairs Scholar, 3(8).
- Kanter, G. P., Mankowitz, T., & Lurie, P. (2025). Conflicts of interest in Federal Vaccine Advisory Committees. JAMA.
In The News
The British Medical Journal
Kanter quoted in a news article about conflicts of interest reforms at the FDA
Featured Faculty: Genevieve Kanter
Statnews.com
Kanter quoted in a story about the lack of transparency into AI device payments to medical providers
Featured Faculty: Genevieve Kanter
Science.org
Kanter quoted in a story about NIH promising to create conflict-of-interest database for scientists
Featured Faculty: Genevieve Kanter